Selective killing of AFP-positive hepatocellular carcinoma cells by adeno-associated virus transfer of the herpes simplex virus thymidine kinase gene

Human Gene Therapy

Volumn 7, Issue 4, 1996, Pages 463-470

  Su, Hua ^a   Chang, Judy C ^a   Xu, Shan Mei ^b   Kan, Yuet Wai ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; GANCICLOVIR; THYMIDINE KINASE;

ADENO ASSOCIATED VIRUS; ANIMAL EXPERIMENT; ARTICLE; CARCINOMA CELL; CELL KILLING; GENE EXPRESSION; GENE TRANSFER; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; TRANSGENIC MOUSE; VIRUS GENE; VIRUS RECOMBINANT;

ADENO-ASSOCIATED VIRUS; ANIMALIA; HERPES; MUS MUSCULUS; SIMPLEXVIRUS; UNIDENTIFIED RETROVIRUS;

EID: 0029921190     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1996.7.4-463     Document Type: Article

References (23)

1. BECK, E., LUDWIG, G., AUERSWALD, E.A., REISS, B., and SCHALLER, H. (1982). Nucleotide sequence and exact localization of the neomycin phosphotransferase gene from transposon Tn5. Gene 19, 327-336.
2. CAMPER, S.A., and TILGHMAN, S.M. (1989). Postnatal repression of the α-fetoprotein gene is enhancer independent. Genes & Dev. 3, 537-546.
3. CHOMCZYNSKI, P., and SACCHI, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform Extraction. Anal. Biochem. 162, 156-159.
4. CULVER, K.W., RAM, Z., WAUBRIDGE, S., ISHII, H., OLDFIELD, E.H., and BLAESE, R.M. (1992). In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 256, 1550-1552.
5. EZZEDDINE, Z.D., MARTUZA, R.L., PLATIKA, D., SHORT, M.P., MALICK, A., CHOI, B., and BREAKEFIELD, X.O. (1991). Selective killing of glioma cells in culture and in vivo by retrovirus transfer of the herpes simplex virus thymidine kinase gene. New Biol. 3, 608-614.
6. FLOTTE, T.R., AFIONE, S.A., and ZEITLIN, P.L. (1994). Adeno-associated virus vector gene expression occurs in nondividing cells in the absence of vector DNA integration. Am. J. Respir. Cell Mol. Biol. 11, 517-521.
7. HEYMAN, R.A., BORRELLI, E., LESLEY, J., ANDERSON, D., RICHMAN, D.D., BAIRD, S.M., HYMAN, R., and EVANS, R.M. (1989). Thymidine kinase obliteration: Creation of transgenic mice with controlled immune deficiency. Proc. Natl. Acad. Sci. USA 86, 2698-2702.
8. HUBER, B.E., RICHARDS, C.A., and KRENITSKY, T.A. (1991). Retroviral-mediated gene therapy for the treatment of hepatocellular carcinoma: An innovative approach for cancer therapy. Proc. Natl. Acad. Sci. USA 88, 8039-8043.
9. KURIYAMA, S., YOSHIKAWA, M., ISHIZAKA, S., TSUJII, T., IKENAKA, K., KAGAWA, T., MORITA, N., and MIKOSHIBA, K. (1991). A potential approach for gene therapy targeting hepatoma using a liver-specific promoter on a retroviral vector. Cell Struct. Funct. 16, 503-510.
10. MOOLTEN, F.L. (1986). Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: Paradigm for a prospective cancer control strategy. Cancer Res. 46, 5276-5281.
11. OSAKI, T., TANIO, Y., TACHIBANA, I., HOSOE, S., KUMAGAI, T., KAWASE, I., OIKAWA, S., and KISHIMOTO, T. (1994). Gene therapy for carcinoembryonic antigen-producing human lung cancer cells by cell type-specific expression of herpes simplex virus thymidine kinase gene. Cancer Res. 54, 5258-5261.
12. PLAUTZ, G., NABEL, E.G., and NABEL, G.J. (1991). Selective elimination of recombinant genes in vivo with a suicide retroviral vector. New Biol. 3, 709-715.
13. RICHARDS, C.A., and HUBER, B.E. (1993). Generation of a transgenic model for retrovirus-mediated gene therapy for hepatocellular carcinoma is thwarted by the lack of transgene expression. Hum. Gene Ther. 4, 143-150.
14. RUSTIGI, V. (1988). Hepatocellular carcinoma. Annu. Rev. Intern. Med. 108, 390-401.
15. SAKAI, M., MORINAGA, T., URANO, Y., WATANABE, K., WEGMANN, T.G., and TAMAOKI, T. (1985). The human α-fetoprotein gene. J. Biol. Chem. 260, 5055-5060.
16. SAMULSKI, R.J., CHANG, L.S., and SHENK, T. (1987). A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral regulation. J. Virol. 61, 3096-3101.
17. SAMULSKI, R.J., CHANG, L.S., and SHENK, T. (1989). Helper-free stocks of recombinant adeno-associated viruses: Normal integration does not require viral gene expression. J. Virol. 63, 3822-3828.
18. TAKAMIYA, Y., SHORT, M.P., EZZEDDINE, Z.D., MOOLTEN, F.L., BREAKEFIELD, X.O., and MARTUZA, R.L. (1992). Gene therapy of malignant brain tumors: a rat glioma line bearing the herpes simplex virus type 1-thymidine kinase gene and wild type retrovirus kills other tumor cells. J. Neurosci. Res. 33, 493-503.
19. THOMAS, K.R., and CAPECCHI, M.R. (1987). Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell 51, 503-512.
20. TILGHMAN, S.M. (1985). The structure and regulation of the α-fetoprotein and albumin genes. In Oxford Surveys in Eukaryotic Genes, vol. 2. N. Maclean, ed. (Oxford University Press, Oxford) pp. 160-206.
21. TILGHMAN, S.M, and BELAYEW, A. (1982). Transcriptional control of the murine albumin:alpha-fetoprotein locus during development. Proc. Natl. Acad. Sci. USA 79, 5254-5257.
22. TYBULEWICZ, L.J., CRAWFORD, C.E., JACKSON, P., BRONSON, R.T., and MULLIGAN, R.C. (1991). Neonatal lathality and lymphopenia in mice with a homozygous disruption of the c-abl protooncogene. Cell 65, 1153-1163.
23. WATANABE, K., SAITO, A., and TAMAOKI, T. (1987). Cell-specific enhancer activity in a far upstream region of the human α-fetoprotein gene. J. Biol. Chem. 262, 4812-4818.